DEF: OneMedNet Corp. Annual Meeting: Reverse Split, Equity Plan on Agenda

OneMedNet Corporation has issued its proxy statement for the 2026 Annual Meeting of Stockholders, detailing proposals including a potential reverse stock split, an equity incentive plan increase, director elections, and auditor ratification.

Summary

• OneMedNet Corporation is holding its 2026 Annual Meeting of Stockholders virtually on September 18, 2026.
• Key proposals include the election of three Class III directors, ratification of WithumSmith+Brown, PC as auditors, approval to increase the share reserve under the 2022 Equity Incentive Plan by 1,000,000 shares, and approval for a reverse stock split with a ratio between 1-for-5 and 1-for-20.
• The record date for voting is August 11, 2026, with 59,286,450 shares of common stock outstanding.
• The company is seeking authorization for the reverse stock split to regain compliance with Nasdaq's minimum bid price requirement of $1.00.
• The 2022 Equity Incentive Plan aims to attract and retain talent by increasing the available share reserve, with 826,417 shares currently available and 4,217,303 shares subject to outstanding RSUs as of August 11, 2026.
• The proxy materials are being distributed on or about August 19, 2026.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a neutral to slightly negative sentiment due to the necessity of a reverse stock split to maintain Nasdaq listing, which often signals underlying business challenges, despite the positive steps in equity incentive plans and director nominations.

Positives

• The company is seeking to enhance its equity incentive program by increasing the share reserve under the 2022 Equity Incentive Plan by 1,000,000 shares, aiming to attract and retain key talent.
• The board composition includes experienced individuals with diverse backgrounds in healthcare, finance, and business leadership.
• The company is actively addressing Nasdaq listing requirements through a proposed reverse stock split, demonstrating a proactive approach to maintaining market access.
• The virtual annual meeting format aims to enhance accessibility and reduce the carbon footprint.

Negatives

• The company is facing a potential delisting from The Nasdaq Capital Market due to not meeting the minimum bid price requirement of $1.00, necessitating a reverse stock split.
• A reverse stock split can be perceived negatively by investors and may not guarantee a sustained increase in stock price.
• The company has experienced a significant number of delinquent Section 16(a) filings, indicating potential internal control or administrative weaknesses.
• There are numerous related-party transactions detailed, including loans and equity issuances, which require careful scrutiny.

Risks

• Failure to regain compliance with Nasdaq's minimum bid price requirement could lead to delisting, negatively impacting stock value, liquidity, and the ability to raise future financing.
• The reverse stock split may not achieve the desired effect of increasing the stock price or maintaining listing compliance.
• The reverse stock split could decrease the liquidity of the stock and potentially lead to increased trading costs for small shareholders.
• The company's stock price may continue to decline due to factors unrelated to the reverse stock split, even if compliance is achieved.
• The equity incentive plan increase, while intended to attract talent, could lead to further dilution for existing shareholders.

Future Outlook

The company's future outlook is heavily dependent on its ability to regain compliance with Nasdaq's minimum bid price requirement, which is the primary driver for the proposed reverse stock split. The approval of the equity incentive plan aims to support future talent acquisition and retention, crucial for long-term growth.

Management Comments

• The Board believes that holding the Annual Meeting virtually is an important step to enhancing accessibility to the meeting and reducing the carbon footprint of our activities.
• We believe that the Company must offer a competitive equity incentive program to successfully attract and retain the best possible candidates for positions of substantial responsibility within the Company.
• A reverse stock split may be necessary to regain compliance with Nasdaqs minimum bid requirement and maintain our listing on The Nasdaq Capital Market, and therefore, our Board currently believes the reverse stock split may be in the best interest of our Company and our stockholders.
• Failure to approve the amendment to effect a reverse stock split could have serious, adverse effects on the Company and its stockholders.

Industry Context

StockSavvy.ai notes that maintaining a listing on major exchanges like Nasdaq is critical for companies in the healthcare technology sector to access capital and maintain investor confidence. Companies often resort to reverse stock splits when facing sustained low stock prices, a common challenge for smaller or growth-stage companies.

Corporate Governance

Related Party Transactions

• Data Knights issued PIPE Notes convertible into Common Stock, with $1.0 million from related party investors including Mr. Green, Dr. Yu, and Dr. Kosasa. PIPE Warrants were also issued to these investors.
• On June 17-19, 2025, holders of approximately $1.66 million of Pre-Closing PIPE Notes, including Mr. Green, Dr. Yu, and Dr. Kosasa, converted their notes into 1,453,174 shares of Common Stock.
• From 2019-2023, the Company issued $12.3 million in Convertible Promissory Notes to related parties, along with 2,976,000 warrants.
• Shareholder loans totaling $954 thousand were issued from April to December 2023 to Dr. Yu and Dr. Kosasa, with one loan converted into a PIPE Note.
• During 2024, $2.0 million in shareholder loans were received from related parties, including Dr. Yu and Dr. Kosasa, with $1.6 million convertible into Common Stock.
• Loan extensions assumed from Data Knights included $3.0 million outstanding as of December 31, 2024, with $2.6 million converted into 3,650,248 shares of Common Stock by two related party investors on June 19, 2025.
• On June 19, 2025, Dr. Kosasa and Dr. Yu converted approximately $3.3 million of shareholder and business combination extension loans into 4,693,296 shares of Common Stock.
• On June 19, 2025, Dr. Kosasa converted approximately $1.6 million of convertible shareholder loans into 2,123,424 shares of Common Stock.
• On June 20, 2025, the Company issued shares to Dr. Kosasa ($500,000) and Dr. Yu ($700,000) through subscription agreements.
• Dr. Kosasa made several investments totaling $2.55 million between August 2025 and June 2026.
• Dr. Yu made investments totaling $850,000 between April and June 2026, and had $0.83 per share compensation converted into 219,429 shares on April 1, 2026.

Stakeholder Impact

• Shareholders are being asked to approve a reverse stock split, which could impact stock price and liquidity, and an increase in the equity incentive plan, which could lead to dilution.
• Employees and consultants may benefit from the proposed increase in the equity incentive plan, aligning their interests with stockholders.
• The company's ability to maintain its Nasdaq listing is crucial for all stakeholders, particularly for investor confidence and access to capital markets.

Next Steps

• Stockholders will vote on the proposals at the 2026 Annual Meeting of Stockholders.
• If approved, the Board of Directors will determine whether to implement the reverse stock split and its specific ratio.
• The company will file the amendment to its Certificate of Incorporation if the reverse stock split is implemented.
• The company will announce preliminary voting results at the Annual Meeting and publish final results in a Form 8-K.

Key Dates

Recommendation

The filing presents a mixed picture. While the company is taking necessary steps to maintain its Nasdaq listing via a reverse stock split and is enhancing its equity incentive plan, the need for such measures suggests underlying business performance challenges. The numerous related-party transactions also warrant caution. Therefore, a 'hold' recommendation is appropriate pending further clarity on the effectiveness of these actions and future business performance.

Keywords

Annual Meeting, Proxy Statement, Reverse Stock Split, Equity Incentive Plan, Director Election, Auditor Ratification, Nasdaq Compliance, Stockholder Vote